Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma

PurposeIt has been indicated that activated hepatic stellate cells (HSCs) play key roles on the pathogenesis of hepatocellular carcinoma (HCC). The purpose of the study was to investigate the potential mechanism in it.MethodsActivation of HSCs, the expression of myocyte enhancer factor 2 (MEF2), class II histone deacetylases (II HDACs) and histone acetylation were analyzed in specimens of primary HCCs, cirrhotic and normal livers. Activated HSCs were identified using anti-a-smooth muscle actin (a-SMA) by Immunohistochemistry (IHC). The levels of expression of MEF2A, MEF2C and II HDACs mRNA and protein were measured by real time quantitative PCR and western blot (WB). Histone acetylation was assessed using anti-acetyl-histone H3, -H4 by WB and IHC. A P value < 0.05 was considered statistically significant.ResultsA-SMA positive activated HSCs were more prominent in HCCs and cirrhotic livers than in normal livers, accompanied by marked expression of MEF2A and MEF2C. The expression of MEF2A, MEF2C and II HDACs, both mRNA and protein, were much more enhanced in HCCs than those in cirrhotic and normal livers (P < 0.05). Histone H3 and H4 were hyperacetylated in HCCs compared with those in cirrhotic and normal livers (P < 0.05). The correlation coefficients between the expression of MEF2 and II HDACs, acetyl-histones were all beyond 0.5.ConclusionsThese data showed a potential molecular mechanism that activated HSCs participate in the pathogenesis of HCCs by overexpression of MEF2 and its consequent impact on histone hyperacetylation. Further investigations aimed at interfering MEF2 expression are needed.

[1]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[2]  P. Marks,et al.  Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.

[3]  H. Huber,et al.  A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. , 2006, Oncogene.

[4]  E. Olson,et al.  MEF 2 : a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation , 1999 .

[5]  M. Yeh,et al.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. L. La Thangue,et al.  Histone deacetylase inhibitors open new doors in cancer therapy. , 2004, Biochemical pharmacology.

[7]  J. Wen,et al.  Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. , 2004, Biochemical pharmacology.

[8]  Saeed Tavazoie,et al.  Mapping Global Histone Acetylation Patterns to Gene Expression , 2004, Cell.

[9]  W. Bickmore,et al.  The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? , 2005, EMBO reports.

[10]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[11]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[12]  L. Mahadevan,et al.  Enhanced histone acetylation and transcription: a dynamic perspective. , 2006, Molecular cell.

[13]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[14]  S. Thung,et al.  Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. , 2008, Liver.

[15]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[16]  J. Bruix,et al.  Treatment of hepatocellular carcinoma. , 2006, Critical reviews in oncology/hematology.

[17]  S. Ferrari,et al.  The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4. , 2001, Journal of cell science.

[18]  D. Gotley,et al.  Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. , 1997, Journal of hepatology.

[19]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[20]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[21]  Eun-Joung Moon,et al.  Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes , 2001, Nature Medicine.

[22]  M E Greenberg,et al.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.

[23]  I. Witz,et al.  The tumor microenvironment in the post-PAGET era. , 2006, Cancer letters.

[24]  Jiuhong Kang,et al.  Nickel-induced histone hypoacetylation: the role of reactive oxygen species. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  Carlos Caldas,et al.  Chromatin modifier enzymes, the histone code and cancer. , 2005, European journal of cancer.

[26]  Jiuhong Kang,et al.  Involvement of histone hypoacetylation in Ni2+-induced bcl-2 down-regulation and human hepatoma cell apoptosis , 2004, JBIC Journal of Biological Inorganic Chemistry.

[27]  T. Liang,et al.  Activation pattern of mitogen‐activated protein kinases in early phase of different size liver isografts in rats , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  S. Archer,et al.  Histone acetylation and cancer. , 1999, Current opinion in genetics & development.

[29]  W. Mikulits,et al.  Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashion , 2006, Journal of cellular physiology.

[30]  Jun O. Liu,et al.  Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. , 2004, Journal of molecular biology.

[31]  E. Olson,et al.  Control of muscle development by dueling HATs and HDACs. , 2001, Current opinion in genetics & development.

[32]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[33]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[34]  H. Gruffat,et al.  MEF2‐mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling , 2002, EMBO reports.

[35]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[36]  B. Howard,et al.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.

[37]  B. Black,et al.  Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor , 2002, Nature Medicine.

[38]  Yufeng Shi,et al.  Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. , 2005, Biochemical pharmacology.

[39]  Stefano Colagrande,et al.  Fibrosis in chronic liver diseases: diagnosis and management. , 2005, Journal of hepatology.

[40]  E. Cho,et al.  Menin represses JunD transcriptional activity in protein kinase Cθ-mediated Nur77 expression , 2005, Experimental & Molecular Medicine.

[41]  S. Friedman,et al.  Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. , 2004, Gastroenterology.

[42]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[43]  S. T. Kim,et al.  Menin represses JunD transcriptional activity in protein kinase C theta-mediated Nur77 expression. , 2005, Experimental & molecular medicine.

[44]  Zhenguo Wu,et al.  Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation , 2005, Molecular and Cellular Biology.

[45]  Yufeng Shi,et al.  Histone hypoacetylation is involved in 1,10-phenanthroline–Cu2+-induced human hepatoma cell apoptosis , 2005, JBIC Journal of Biological Inorganic Chemistry.

[46]  Y. Tokusashi,et al.  Expression of NGF in hepatocellular carcinoma cells with its receptors in non‐tumor cell components , 2005, International journal of cancer.